Cardiff Oncology
CRDF
CRDF
73 hedge funds and large institutions have $223M invested in Cardiff Oncology in 2021 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 32 increasing their positions, 13 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
53% less capital invested
Capital invested by funds: $479M → $223M (-$256M)
56% less call options, than puts
Call options by funds: $3.69M | Put options by funds: $8.46M
Holders
73
Holding in Top 10
2
Calls
$3.69M
Puts
$8.46M
Top Buyers
| 1 | +$16.5M | |
| 2 | +$7.78M | |
| 3 | +$7.4M | |
| 4 |
CA
Corriente Advisors
Fort Worth,
Texas
|
+$7.27M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$5.55M |
Top Sellers
| 1 | -$59.2M | |
| 2 | -$23.4M | |
| 3 | -$10.1M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$9.53M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.47M |